Alice YY Cheng, MD, FRCPC - Addressing Unmet Needs in Patients With T2D and CKD: Stepping Up Care to Improve Cardiorenal Outcomes PeerVoice Endocrinology & Metabolic Disorders Video
-
- Science
Visit https://www.peervoice.com/ETM860 to view the entire programme with slides. After completing “Alice YY Cheng, MD, FRCPC - Addressing Unmet Needs in Patients With T2D and CKD: Stepping Up Care to Improve Cardiorenal Outcomes”, participants will be able to: Outline morbidity and mortality risks for patients with type 2 diabetes (T2D) and chronic kidney disease (CKD) and current unmet needs in this patient population; Discuss best practices to identify and assess risk in patients with T2D and early CKD in primary care; Evaluate the role of non-steroidal mineralocorticoid receptor antagonist (nsMRA) therapy in the context of current treatment options for patients with T2D and CKD; and Apply best practices to monitor response and mitigate or manage safety concerns in patients receiving nsMRA therapy.
Visit https://www.peervoice.com/ETM860 to view the entire programme with slides. After completing “Alice YY Cheng, MD, FRCPC - Addressing Unmet Needs in Patients With T2D and CKD: Stepping Up Care to Improve Cardiorenal Outcomes”, participants will be able to: Outline morbidity and mortality risks for patients with type 2 diabetes (T2D) and chronic kidney disease (CKD) and current unmet needs in this patient population; Discuss best practices to identify and assess risk in patients with T2D and early CKD in primary care; Evaluate the role of non-steroidal mineralocorticoid receptor antagonist (nsMRA) therapy in the context of current treatment options for patients with T2D and CKD; and Apply best practices to monitor response and mitigate or manage safety concerns in patients receiving nsMRA therapy.
46 min